Wegener's granulomatosis: A challenging disease for otorhinolaryngologists

References

• Wegener F. Uber generalisierte, septische Gefasser-krankungen. Verh Dtsch Ges Pathol 1936; 29: 202–10
   Google Scholar
• Wegener F. Uber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. Beitr Pathol 1939; 102: 36–58
   Google Scholar
• Godman GC, Churg J. Wegener's granulomatosis. Pathology and review of the literature. Arch Pathol 1954; 58: 533–53
   PubMedGoogle Scholar
• Koldingsnes W, Nossent JC. Increasing incidence of Wegener's granulomatosis in a stable Caucasian population, during the 15 years period from 1984–1998 [abstract]. Arthritis Rheum 1984; 42((Suppl))S318
   Google Scholar
• Hoffman GS, Kerr GS, Levitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: analysis of 158 patients. Ann Intern Med 1992; 116: 488–98
   PubMed Web of Science ®Google Scholar
• Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis. Estimates of the 5-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996; 39: 87–92
   PubMed Web of Science ®Google Scholar
• Bajema IM, Hagen EC, Van Der Woude FJ, Bruijn JA. Wegener's granulomatosis: meta-analysis of 349 literary case reports. J Lab Clin Med 1997; 129: 17–22
   PubMed Web of Science ®Google Scholar
• Harper L, Cockwell P, Savage COS. Case of propylthiouracil-induced ANCA-associated small vessel vasculitis. Nephrol Dial Transplant 1998; 13: 455–8
   PubMed Web of Science ®Google Scholar
• Schaffer JV, Davidson DM, McNiff JM, Bolognia JC. Perinuclear antineutrophil cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 2001; 44: 198–206
   PubMed Web of Science ®Google Scholar
• Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 1994; 120: 12–7
   PubMed Web of Science ®Google Scholar
• Boudewyns A, Verbelen J, Koekelkoren E, Van Offel J, Van de Heyning P. Wegener's granulomatosis triggered by infection?. Acta Otorhinolaryngol Belg 2001; 55: 57–63
   PubMedGoogle Scholar
• Hogan SL, Satterly KK, Dooley MA, Nackman PH, Jennette JC, Falk RJ. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 2001; 12: 134–42
   PubMed Web of Science ®Google Scholar
• Harris A, Chang G, Vadas M, Gillis D. ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis. J Clin Pathol 1999; 52: 670–6
   PubMed Web of Science ®Google Scholar
• Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, et al. International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 2000; 113: 455–6
   PubMed Web of Science ®Google Scholar
• Schmitt WH, van der Woude FJ. Clinical applications of antineutrophil cytoplamic antibody testing. Curr Opin Rheumatol 2004; 16: 9–17
   PubMedGoogle Scholar
• Harper L, Savage COS. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol 2000; 190: 349–59
   PubMed Web of Science ®Google Scholar
• Fauci AS, Wolff SM. Wegener's granulomatosis: studies in 18 patients and a review of the literature. Medicine (Baltimore) 1973; 52: 535–61
   PubMed Web of Science ®Google Scholar
• McDonald TJ, De Remee RA. Wegener's granulomatosis. Laryngoscope 1993; 93: 220–31
   Google Scholar
• Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994; 87: 671–8
   Google Scholar
• Langford CA. Wegener granulomatosis. Am J Med Sci 2001; 321: 76–82
   PubMed Web of Science ®Google Scholar
• McDonald TJ, DeRemee RA, Kern EB, Harrison EG. Nasal manifestations of Wegener's granulomatosis. Laryngoscope 1974; 84: 2101–12
   PubMed Web of Science ®Google Scholar
• Rasmussen N. Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective. Curr Opin Rheumatol 2001; 13: 3–11
   PubMed Web of Science ®Google Scholar
• Illum P, Thorling K. Wegener's granulomatosis: longterm results of treatment. Ann Otol Rhinol Laryngol 1981; 90: 231–4
   PubMed Web of Science ®Google Scholar
• Kornblut AD, Wolff SM, Fauci AS. Ear disease in patients with Wegener's granulomatosis. Laryngoscope 1982; 92: 713–7
   PubMed Web of Science ®Google Scholar
• Fauci AS, Haynes BF. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76–85
   PubMed Web of Science ®Google Scholar
• Choufani G, Hassid S, Hernebert D. Otological manifestations of Wegener's granulomatosis. Acta Otorhinolaryngol Belg 1991; 45: 375–9, (in French)
   PubMedGoogle Scholar
• Lebovics RS, Hoffman GS, Leavitt RY, Kerr GS, Travis WD, Kammerer W, et al. The management of subglottic stenosis in patients with Wegener's granulomatosis. Laryngoscope 1992; 102: 1341–5
   PubMed Web of Science ®Google Scholar
• Almadori G, Trivelli M, Scarano E, Cadoni G. Misleading clinical features in Wegener's granulomatosis, A case report. J Laryngol Otol 1997; 11: 746–8
   Web of Science ®Google Scholar
• Davenport A. “False positive” perinuclear and cytoplasmic anti-neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis. Clin Nephrol 1992; 37: 124–30
   PubMed Web of Science ®Google Scholar
• Macias JD, Wackym PA, McCabe BF. Early diagnosis of otologic Wegener's granulomatosis using the serologic marker cANCA. Ann Otol Rhinol Laryngol 1993; 102: 337–41
   PubMed Web of Science ®Google Scholar
• Cadoni G, Agostino S, Campobasso E, Vulpiani P, Manna R, Galli J. Early diagnosis and stage-adapted treatment of Wegener's granulomatosis. J Laryngol Otol 2003; 117: 208–11
   PubMed Web of Science ®Google Scholar
• Nischino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurologic involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993; 33: 4–9
   PubMed Web of Science ®Google Scholar
• De Groot K, Schmidt DK, Arlt AC, Gross WL, Reinhold-Keller E. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 2001; 58: 1215–21
   PubMedGoogle Scholar
• Laforgia A, Di Venere D, Poli M. Wegener's syndrome (or granulomatosis), A clinical case. Minerva Stomatol 1993; 42: 547–52
   PubMedGoogle Scholar
• Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, et al. Wegener's granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 1993; 122(1)26–31
   PubMed Web of Science ®Google Scholar
• Gaughan RK, DeSanto LW, McDonald TJ. Use of anticytoplasmic autoantibodies in the diagnosis of Wegener's granulomatosis with subglottic stenosis. Laryngoscope 1990; 100: 561–3
   PubMed Web of Science ®Google Scholar
• Matt BH. Wegener's granulomatosis, acute laryngotracheal obstruction and death in a 17 year old female: case report and review of the literature. Int J Pediatr Otorhinolaryngol 1996; 37: 163–72
   PubMed Web of Science ®Google Scholar
• Cohen T, Huitema MG, Henè RJ, Sluiter WJ, The TH, Van der Hem GK, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on anti-neutrophil cytoplasmic antibody titre. Lancet 1990; 336: 709–11
   PubMed Web of Science ®Google Scholar
• Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, et al. Wegener's granulomatosis. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Society Research Committee. Q J Med 1992; 302: 427–38
   Google Scholar
• Bolley R, Mistry-Burchardi N, Samtleben W. Wegener granulomatosis and microscopic polyangiitis. Diagnostic and clinical results in 54 patients with long-term follow-up. Dtsch Med Wochenschr 2000; 125: 1519–25
   PubMed Web of Science ®Google Scholar
• Carrie S, Hughes KB, Watson MG. Negative ANCA in Wegener's granulomatosis. J Laryngol Otol 1994; 108: 420–2
   PubMed Web of Science ®Google Scholar
• Devaney KO, Ferlito A, Hunter BC, et al. Wegener's granulomatosis of the head and neck. Ann Otol Rhinol Laryngol 1998; 107: 439–45
   PubMed Web of Science ®Google Scholar
• PausJenssen ES, Cockcroft DW. A case report of Wegener granulomatosis treated only with corticosteroids for 30 years. Ann Allergy Asthma Immunol 2003; 91: 82–5
   PubMed Web of Science ®Google Scholar
• DeRemee RA. Wegener's granulomatosis. Curr Opin Pulm Med 1995; 1: 363–7
   PubMedGoogle Scholar
• Thomas-Golbanov C, Sridharan S. Novel therapies in vasculitis. Exp Opin Invest Drugs 2001; 10: 1279–89
   PubMed Web of Science ®Google Scholar
• Frasca GM, Zoumparidis NG, Borgnino LC, Neri L, Vangelisti A, Bonomini V. Plasma exchange treatment in rapidly progressive glomerulonephritis associated with anti-neutrophil cytoplasmic autoantibodies. Int J Artif Organs 1992; 15: 181–4
   PubMed Web of Science ®Google Scholar
• Fields CL, Ossario MA, Roy TM, Bunke CM. Wegener's granulomatosis complicated by pregnancy, A case report. J Reprod Med 1991; 36: 463–6
   PubMed Web of Science ®Google Scholar
• Birck R, Warnatz K, Lorenz HM, Choi M, Haubitz M, Grunke M, et al. 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy. J Am Soc Nephrol 2003; 14: 440–7
   PubMed Web of Science ®Google Scholar